Platinum-induced neurotoxicity: A review of possible mechanisms

被引:12
作者
Ozkan Kanat [1 ]
Hulya Ertas [1 ]
Burcu Caner [1 ]
机构
[1] Department of Medical Oncology,Uludag University Faculty of Medicine
关键词
Cisplatin; Dorsal root ganglion; Mechanism; Oxaliplatin; Neurotoxicity; Neuropathic pain; Sodium channel;
D O I
暂无
中图分类号
R730.53 [化学(药物)疗法];
学科分类号
100214 ;
摘要
Patients treated with platinum-based chemotherapy frequently experience neurotoxic symptoms, which may lead to premature discontinuation of therapy. Despitediscontinuation of platinum drugs, these symptoms can persist over a long period of time. Cisplatin and oxaliplatin, among all platinum drugs, have significant neurotoxic potential. A distal dose-dependent symmetrical sensory neuropathy is the most common presentation of platinum neurotoxicity. DNA damage-induced apoptosis of dorsal root ganglion(DRG) neurons seems to be the principal cause of neurological symptoms. However, DRG injury alone cannot explain some unique symptoms such as cold-aggravated burning pain affecting distal extremities that is observed with oxaliplatin administration. In this article, we briefly reviewed potential mechanisms for the development of platinum drugs-associated neurological manifestations.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 27 条
[1]  
Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons[J] . Markus Leo,Linda-Isabell Schmitt,Martin Erkel,Margarita Melnikova,Jürgen Thomale,Tim Hagenacker.Experimental Neurology . 2017
[2]  
Cisplatin induces mitochondrial deficits in Drosophila larval segmental nerve[J] . Jewel L. Podratz,Han Lee,Patrizia Knorr,Stephanie Koehler,Steven Forsythe,Kelsey Lambrecht,Suzette Arias,Kiley Schmidt,Gabrielle Steinhoff,Georgiy Yudintsev,Amy Yang,Eugenia Trushina,Anthony Windebank.Neurobiology of Disease . 2017
[3]   Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity [J].
Yan, Fang ;
Liu, Johnson J. ;
Ip, Virginia ;
Jamieson, Stephen M. F. ;
McKeage, Mark J. .
JOURNAL OF NEUROCHEMISTRY, 2015, 135 (06) :1099-1112
[4]  
Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol[J] . Alexia Kagiava,George Theophilidis,Irene Sargiannidou,Kyriacos Kyriacou,Kleopas A. Kleopa.Neuropharmacology . 2015
[5]  
Glial role in oxaliplatin-induced neuropathic pain[J] . Lorenzo Di Cesare Mannelli,Alessandra Pacini,Laura Micheli,Alessia Tani,Matteo Zanardelli,Carla Ghelardini.Experimental Neurology . 2014
[6]  
Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: Effects of selective activation[J] . Lorenzo Di Cesare Mannelli,Alessandra Pacini,Carlo Matera,Matteo Zanardelli,Tommaso Mello,Marco De Amici,Clelia Dallanoce,Carla Ghelardini.Neuropharmacology . 2014
[7]   Morphologic Features and Glial Activation in Rat Oxaliplatin-Dependent Neuropathic Pain [J].
Mannelli, Lorenzo Di Cesare ;
Pacini, Alessandra ;
Bonaccini, Laura ;
Zanardelli, Matteo ;
Mello, Tommaso ;
Ghelardini, Carla .
JOURNAL OF PAIN, 2013, 14 (12) :1585-1600
[8]  
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis[J] . Susanna B. Park,David Goldstein,Arun V. Krishnan,Cindy S‐Y Lin,Michael L. Friedlander,James Cassidy,Martin Koltzenburg,Matthew C. Kiernan.CAA Cancer Journal for Clinicians . 2013 (6)
[9]  
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Na v 1.6 in peripheral pain pathways[J] . Jennifer R. Deuis,Katharina Zimmermann,Andrej A. Romanovsky,Lourival D. Possani,Peter J. Cabot,Richard J. Lewis,Irina Vetter.Pain . 2013 (9)
[10]   Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer [J].
Lucchetta, Marta ;
Lonardi, Sara ;
Bergamo, Francesca ;
Alberti, Paola ;
Velasco, Roser ;
Argyriou, Andreas A. ;
Briani, Chiara ;
Bruna, Jordi ;
Cazzaniga, Marina ;
Cortinovis, Diego ;
Cavaletti, Guido ;
Kalofonos, Haralabos P. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) :899-902